Abstract
This Commentary discusses the feasibility of vaccines against melanoma-associated differentiation antigens for treatment of lymphangioleiomyomatosis.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have